Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AKL-T09 is a **digital therapeutic intervention** designed as a video game-based platform ("EVO Words") that aims to improve attention and cognitive function, particularly in children with Attention Deficit Hyperactivity Disorder (ADHD)[5][7][2]. The intervention requires subjects to spell as many words as possible by connecting letters in a grid within a fixed period. Developed by Akili Interactive, AKL-T09 operates as a gamified cognitive training tool and is assessed in randomized controlled trials as a non-pharmacological therapy for pediatric ADHD and related cognitive deficits. Its mechanism of action is not molecular but instead involves targeted cognitive stimulation to enhance attentional processing and executive function domains. Improvements in attention are assessed using validated neuropsychological batteries such as the Test of Variables of Attention (TOVA)[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AKL-T09.